Coronavirus Information
COVID-19 Information
As we continue to monitor the rapidly evolving situation around the COVID-19 pandemic, FASEB remains committed to the health and safety of biological and biomedical researchers, as well as the scientific enterprise. COVID-19 is an unprecedented challenge of incredible scale and significance, and FASEB is committed to providing you with relevant information and resources as the pandemic evolves. These resources are compiled here to help you stay informed. Please check back frequently for updates. (If you are a member of the public, please visit the CDC and FEMA.)
Federal Agencies
National Institutes of Health
- Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies
- Notice of Correction to PAR-20-256: Clarification on Frequency of Usage Reports
- Effects of Smoking and Vaping on the Risk and Outcome of COVID-19 Infection
- Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019
- Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
- Information for NIH Applicants and Recipients of NIH Funding Related to COVID-19
- Applicant/Recipient COVID-19 Update History
- Frequently Asked Questions on COVID-19 Flexibilities
- Contingency Planning for Animal Care and Use Programs
- All COVID-19 Research Funding
- NIH-Wide Strategic Plan for COVID-19 Research
- Exceptions to Use of a Single IRB During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (October 23)
- Considerations for New and Ongoing Human Subjects Research During the COVID-19 Public Health Emergency (October 13)
- Notice of Limited Availability of Research Non-human Primates (September 11)
- Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic (August 12)
- Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
National Science Foundation
- NSF Implementation of OMB Memorandum M-20-26
- Important Notice No. 146 - NSF Letter to Community Regarding COVID-19
- Impact on Existing Deadline Dates
- Impact on Solicitations
- NSF Guidance on the Effects of COVID-19 on Human Subjects Research
- NSF Guidance on the Effects of COVID-19 on Vertebrate Animal Research
- Using NSF-Funded Research in the Fight Against COVID
U.S. Centers for Disease Control and Prevention
- Information for Laboratories about Coronavirus (October 16)
- Frequently Asked Questions about Coronavirus for Laboratories
U.S. Department of Energy
U.S. Department of Veteran Affairs
U.S. Food and Drug Administration
FASEB Communications
- Vaccines: Essential Weapons in the Fight Against Disease
- FASEB Urges Congress to Provide Additional Coronavirus Funding to NIH and NSF
- Combatting COVID-19: The Critical Role of Nonhuman Primate Research (slide deck from recorded webinar)
- Rethinking the Role of Hydroxychloroquine in the Treatment of COVID‐19 (April 29)
- The Role of Growth Factor Receptors in Viral Infections: An Opportunity for Drug Repurposing against Emerging Viral Diseases such as COVID‐19? (April 9)
FASEB Member Society and Partners' Coronavirus Resources
- American Physiological Society
- American Society for Biochemistry and Molecular Biology
- American Society for Microbiology
- American Society for Nutrition
- American Society for Pharmacology and Experimental Therapeutics
- American Society of Human Genetics
- American Veterinary Medical Association
- Americans for Medical Progress
- Association for Molecular Pathology
- Endocrine Society